Abstract
Actual strategies to delay progression of diabetic nephropathy provide imperfect protection when started late in the course of the disease. Ohtomo et al. now demonstrate that thiazolidinedione treatment was associated with a remarkable improvement in proteinuria and renal function, offering a new potential treatment for diabetic nephropathy. © 2007 International Society of Nephrology.
Cite
CITATION STYLE
APA
Perico, N., & Remuzzi, G. (2007). Inhibition of TGF-β expression: A novel role for thiazolidinediones to implement renoprotection in diabetes. Kidney International. Nature Publishing Group. https://doi.org/10.1038/sj.ki.5002654
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free